208 related articles for article (PubMed ID: 31168212)
1. EFFECT OF GROWTH HORMONE THERAPY IN CHILDREN WITH PRADER-WILLI SYNDROME - OUR FIRST EXPERIENCES.
Stipančić G; Požgaj Šepec M; La Grasta Sabolić L
Acta Clin Croat; 2018 Dec; 57(4):744-755. PubMed ID: 31168212
[TBL] [Abstract][Full Text] [Related]
2. Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader-Willi syndrome.
Cheng RQ; Ying YQ; Qiu ZQ; Fu JF; Gong CX; Yang YL; Shi W; Li H; Ma MS; Wang CY; Liu M; Chen JJ; Su C; Luo XP; Luo FH; Lu W
World J Pediatr; 2023 May; 19(5):438-449. PubMed ID: 36564648
[TBL] [Abstract][Full Text] [Related]
3. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
Yang A; Choi JH; Sohn YB; Eom Y; Lee J; Yoo HW; Jin DK
Orphanet J Rare Dis; 2019 Sep; 14(1):216. PubMed ID: 31511031
[TBL] [Abstract][Full Text] [Related]
5. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review.
Tan Q; Orsso CE; Deehan EC; Triador L; Field CJ; Tun HM; Han JC; Müller TD; Haqq AM
Obes Rev; 2020 May; 21(5):e12992. PubMed ID: 31889409
[TBL] [Abstract][Full Text] [Related]
7. Visceral adipose tissue resides within the reference range in children with Prader-Willi syndrome receiving nutritional intervention on a regular basis.
Koizumi M; Ida S; Shoji Y; Nishimoto Y; Etani Y; Kawai M
Endocr J; 2020 Oct; 67(10):1029-1037. PubMed ID: 32565499
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably.
Lindgren AC; Hagenäs L; Müller J; Blichfeldt S; Rosenborg M; Brismar T; Ritzén EM
Acta Paediatr; 1998 Jan; 87(1):28-31. PubMed ID: 9510443
[TBL] [Abstract][Full Text] [Related]
9. Effects of early recombinant human growth hormone treatment in young Chinese children with Prader-Willi syndrome.
Gao Y; Yang LL; Dai YL; Shen Z; Zhou Q; Zou CC
Orphanet J Rare Dis; 2023 Feb; 18(1):25. PubMed ID: 36750945
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment.
Festen DA; Visser TJ; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2007 Sep; 67(3):449-56. PubMed ID: 17716335
[TBL] [Abstract][Full Text] [Related]
11. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
Scheermeyer E; Harris M; Hughes I; Crock PA; Ambler G; Verge CF; Bergman P; Werther G; Craig ME; Choong CS; Davies PSW;
Growth Horm IGF Res; 2017 Jun; 34():1-7. PubMed ID: 28427039
[TBL] [Abstract][Full Text] [Related]
12. Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up.
Schmidt H; Pozza SB; Bonfig W; Schwarz HP; Dokoupil K
J Pediatr Endocrinol Metab; 2008 Jul; 21(7):651-5. PubMed ID: 18780599
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the effect of recombinant human growth hormone treatment on sleep-related breathing disorders in toddlers with Prader-Willi syndrome: a one-year retrospective cohort study.
Guo H; Fu J; Zhou Y; Luo F; Cheng R
BMC Pediatr; 2024 Jan; 24(1):32. PubMed ID: 38200464
[TBL] [Abstract][Full Text] [Related]
14. [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy].
Lämmer C; Weimann E
Wien Med Wochenschr; 2007 Feb; 157(3-4):82-8. PubMed ID: 17340066
[TBL] [Abstract][Full Text] [Related]
15. Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review.
Jin YY; Luo FH
Eur J Pediatr; 2024 Mar; 183(3):1021-1036. PubMed ID: 37987848
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.
Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Christiansen JS; Höybye C
Endocrine; 2012 Apr; 41(2):191-9. PubMed ID: 22081257
[TBL] [Abstract][Full Text] [Related]
17. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
[TBL] [Abstract][Full Text] [Related]
18. Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update.
Butler MG; Miller JL; Forster JL
Curr Pediatr Rev; 2019; 15(4):207-244. PubMed ID: 31333129
[TBL] [Abstract][Full Text] [Related]
19. Early Diagnosis in Prader-Willi Syndrome Reduces Obesity and Associated Co-Morbidities.
Kimonis VE; Tamura R; Gold JA; Patel N; Surampalli A; Manazir J; Miller JL; Roof E; Dykens E; Butler MG; Driscoll DJ
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31698873
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone receptor (GHR) gene polymorphism and Prader-Willi syndrome.
Butler MG; Roberts J; Hayes J; Tan X; Manzardo AM
Am J Med Genet A; 2013 Jul; 161A(7):1647-53. PubMed ID: 23696513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
